BIT:AMPHealthcare
Amplifon (BIT:AMP) Margins Strengthen As Growth And Cash Flow Improve
Amplifon walked into this earnings day with the stock up over the past month yet slightly weaker over the past week, a classic setup for investors to test whether recent optimism was justified. The headline is clear: profitability, not just sales, stole the show. Q2 revenue landed at €606m while adjusted EBITDA margin reached 25.8%, which was higher than a year ago. The market now has to decide whether a richer P/E and a modest dividend are still a problem when the core hearing care business...